Phase 2 Trial of Nonpegylated Doxorubicin (Myocet) as Second-Line Treatment in Advanced or Recurrent Endometrial Cancer
Alessia Di Legge, Ilaria Nausica Trivellizzi, Maria Cristina Moruzzi, Adele Pesce, Giovanni Scambia, Domenica Lorusso
International Journal of Gynecologic Cancer Nov 2011, 21 (8) 1446-1451; DOI: 10.1097/IGC.0b013e31822d754e